Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Syed Naqvi to Antibodies, Monoclonal, Humanized

This is a "connection" page, showing publications Syed Naqvi has written about Antibodies, Monoclonal, Humanized.

 
Connection Strength
  
 
 
0.200
  
  1. Vince M, Naqvi SMH, Pellini B, Verbosky M, Melzer D. Real-world comparison of the efficacy and safety of atezolizumab versus durvalumab in extensive-stage small cell lung cancer. Lung Cancer. 2024 Dec; 198:107999.
    View in: PubMed
    Score: 0.200
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.